![Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study - The Lancet Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study - The Lancet](https://www.thelancet.com/cms/attachment/5f230407-9484-4d20-be57-b374b7936e45/gr1.gif)
Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study - The Lancet
![Frontiers | Research on the Mechanism and Prevention of Hypertension Caused by Apatinib Through the RhoA/ROCK Signaling Pathway in a Mouse Model of Gastric Cancer Frontiers | Research on the Mechanism and Prevention of Hypertension Caused by Apatinib Through the RhoA/ROCK Signaling Pathway in a Mouse Model of Gastric Cancer](https://www.frontiersin.org/files/Articles/873829/fcvm-09-873829-HTML-r2/image_m/fcvm-09-873829-g001.jpg)
Frontiers | Research on the Mechanism and Prevention of Hypertension Caused by Apatinib Through the RhoA/ROCK Signaling Pathway in a Mouse Model of Gastric Cancer
Προϊόντα | Winter Sales -40% Έκπτωση - Ανακαλύψτε την Χειμωνιάτικη Συλλογή με Έκπτωση στο KayakFashion.gr - Δωρεάν Μεταφορικά για αγορές 70€ - Επώνυμα Ρούχα, Παπούτσια, Αξεσουάρ για τον Άνδρα και την Γυναίκα
![Adverse event burden in older patients with CLL receiving bendamustine plus rituximab or ibrutinib regimens: Alliance A041202 | Leukemia Adverse event burden in older patients with CLL receiving bendamustine plus rituximab or ibrutinib regimens: Alliance A041202 | Leukemia](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41375-021-01342-x/MediaObjects/41375_2021_1342_Fig1_HTML.png)